Related Experiment Video

Updated: May 14, 2026

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
09:16

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration

Published on: January 22, 2016

Effects of repeated exposure to MDMA on 5HT1a autoreceptor function: behavioral and neurochemical responses to

Susan Schenk1, Blaine Abraham, Dane Aronsen

  • 1School of Psychology, Victoria University of Wellington, P.O. Box 600, Wellington, New Zealand. susan.schenk@vuw.ac.nz

Psychopharmacology
|January 29, 2013
PubMed

Insights

Repeated 3,4-methylenedioxymethamphetamine (MDMA) exposure decreases serotonin (5-HT) levels. This study found no evidence of 5-HT1a autoreceptor supersensitivity, suggesting reduced tryptophan hydroxylase activity contributes to MDMA-induced serotonin deficits.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Neurochemistry

Background:

  • Repeated 3,4-methylenedioxymethamphetamine (MDMA) administration consistently reduces brain serotonin (5-HT) tissue levels.
  • The neurochemical consequences of MDMA exposure, particularly concerning serotonin autoreceptor sensitivity, require further investigation.

Purpose of the Study:

  • To investigate whether repeated MDMA exposure leads to increased sensitivity of the serotonin 5-HT1a autoreceptor.
  • To explore the neurochemical mechanisms underlying MDMA-induced serotonin depletion.

Main Methods:

  • Rats were administered MDMA (10 mg/kg) or saline repeatedly over a single day.
  • Two weeks post-exposure, behavioral (lower lip retraction, hypoactivity) and neurochemical (5-hydroxytryptophan accumulation) responses to the 5-HT1a agonist 8-OHDPAT were assessed.
  • Tissue levels of serotonin (5-HT) and 5-hydroxytryptophan (5-HTP) were measured.

Main Results:

  • MDMA exposure significantly decreased brain 5-HT levels and 5-HTP accumulation, indicating reduced serotonin synthesis.
  • The behavioral responses to 8-OHDPAT (lower lip retraction and hypoactivity) were comparable between MDMA-treated and control groups.
  • These findings suggest that the 5-HT1a autoreceptor did not become supersensitive following MDMA exposure.

Conclusions:

  • The decrease in brain serotonin levels following repeated MDMA exposure is associated with reduced tryptophan hydroxylase activity.
  • MDMA-induced serotonin deficits are not explained by an increased sensitivity of the 5-HT1a autoreceptor.
  • This research clarifies the neurochemical adaptations following MDMA exposure, highlighting alterations in serotonin synthesis pathways.

More Related Videos

Assessment of Cocaine-induced Behavioral Sensitization and Conditioned Place Preference in Mice10:28

Assessment of Cocaine-induced Behavioral Sensitization and Conditioned Place Preference in Mice

Published on: February 18, 2016

HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice07:30

HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice

Published on: July 9, 2016

Related Concept Videos

Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
CNS Stimulants: Psychedelic Agents01:22

CNS Stimulants: Psychedelic Agents

Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...
Hallucinogens and Psychedelics01:27

Hallucinogens and Psychedelics

Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains delta-9-tetrahydrocannabinol (THC)...
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...